financetom
Business
financetom
/
Business
/
Zoetis' Q3 Adjusted Earnings, Revenue Rise; Lifts 2024 Guidance
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Zoetis' Q3 Adjusted Earnings, Revenue Rise; Lifts 2024 Guidance
Nov 4, 2024 7:10 AM

07:32 AM EST, 11/04/2024 (MT Newswires) -- ZTS (ZTS) reported Q3 adjusted earnings Monday of $1.58 per diluted share, up from $1.36 a year earlier.

Analysts polled by Capital IQ expected $1.46.

Revenue for the quarter ended Sept. 30 was $2.39 billion, up from $2.15 billion a year earlier.

Analysts surveyed by Capital IQ expected $2.29 billion.

For the full-year 2024, the company said it now expects adjusted diluted EPS in the range of $5.86 to $5.92, up from its prior outlook of $5.78 to $5.88. Analysts polled by Capital IQ expect $5.83.

Revenue for the year is now projected to be between $9.20 billion to $9.30 billion, up from its prior range of $9.10 billion to $9.25 billion. Analysts surveyed by Capital IQ expect $9.19 billion.

Zoetis' ( ZTS ) stock fell 0.5% in recent Monday premarket activity.

Price: 181.00, Change: -0.95, Percent Change: -0.52

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
What's Going With Apellis Pharmaceuticals Stock Friday?
What's Going With Apellis Pharmaceuticals Stock Friday?
Sep 21, 2024
Apellis Pharmaceuticals, Inc. ( APLS ) shares are moving lower Friday after the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency, following a re-examination, confirmed its June 2024 negative opinion on the marketing authorization application of intravitreal pegcetacoplan for the treatment of geographic atrophy secondary to age-related macular degeneration. The Details: Over time, geographic atrophy...
--FTC Sues PBMs of CVS, Cigna, UnitedHealth for Allegedly Inflating Insulin Prices
--FTC Sues PBMs of CVS, Cigna, UnitedHealth for Allegedly Inflating Insulin Prices
Sep 21, 2024
12:07 PM EDT, 09/20/2024 (MT Newswires) -- Price: 57.44, Change: -0.96, Percent Change: -1.65 ...
US House votes narrowly to repeal Biden administration EPA tailpipe emissions rules
US House votes narrowly to repeal Biden administration EPA tailpipe emissions rules
Sep 21, 2024
WASHINGTON (Reuters) - The U.S. House of Representatives on Friday voted narrowly to repeal clean vehicle rules adopted in March to cut fleetwide tailpipe emissions by 50% over 2026 levels by 2032. House Republicans said the Environmental Protection Agency's final regulation would effectively push gas-powered vehicles out of the U.S. marketplace. The White House on Friday said President Joe Biden...
US decision on Nippon's bid for US Steel pushed back until after election
US decision on Nippon's bid for US Steel pushed back until after election
Sep 21, 2024
Sept 17 (Reuters) - A national security committee reviewing Nippon Steel's ( NISTF ) bid for U.S. Steel granted a request by the companies to refile their bid for approval of the deal, a person familiar with the matter said on Tuesday, giving the Biden administration until after the U.S. presidential election to make a decision about whether to block...
Copyright 2023-2026 - www.financetom.com All Rights Reserved